PITTSBURGH, Aug. 25 /PRNewswire/ -- CardiacAssist has been named by the Pittsburgh Business Times as the fastest growing manufacturing company in Pittsburgh. CardiacAssist develops, manufactures and markets cardiac assist devices, including the TandemHeart® PTVA® System (www.cardiacassist.com), which is used in 17 of the top 20 heart and heart surgery hospitals in the U.S. and 11 of the nation’s top 14 hospitals overall.
The Pittsburgh Business Times’ annual Pittsburgh 100 rankings were announced last night at the 10th annual Pittsburgh 100 ceremony, which honors the fastest-growing, privately held companies in the region. The award measures a company’s revenue growth over the previous three years. CardiacAssist ranked first in the manufacturing category and 7th overall among Pittsburgh area companies.
“It is gratifying to be recognized by the Pittsburgh Business Times for all the hard work and effort that has gone into making CardiacAssist a strong and contributing part of the Pittsburgh economy,” said CardiacAssist, Inc. CEO Michael Garippa. “This also validates the efforts of the Board of Directors and shareholders to build a respected company in the medical device manufacturing industry. It has truly been a team effort.”
CardiacAssist, Inc. is a leader in providing percutaneous extracorporeal circulatory support by providing the TandemHeart System to more than 70 leading critical care centers around the world. The device has received FDA 510(k) clearance for short-term use and is the only FDA approved device of its kind in the U.S.
The TandemHeart System helps restore blood circulation through a cardiac catheterization procedure in as little as 30 minutes and can provide up to five liters per minute (lpm) of blood flow.
About CardiacAssist
Founded in 1996, CardiacAssist, Inc. is a privately held, Pittsburgh-based medical device company that develops, manufactures and markets innovative products designed to provide cardiologists and cardiac surgeons with minimally invasive solutions for providing extracorporeal circulatory support. Its vision is to help advance the treatment of heart disease by bridging gaps in current treatment methodologies.
This press release may contain certain forward-looking statements that relate to CardiacAssist’s future business and financial performance. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein.
Media Contact: Dan Snyders Armada Medical Marketing 303-623-1190 x230 dan@armadamedical.com Monica Bush CardiacAssist, Inc., 412-963-7770 x247 mbush@cardiacassist.com
Source: CardiacAssist, Inc.
